Sight Sciences Inc.
Organization details
- Legal name
- Sight Sciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Menlo Park
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SGHT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001531177
- EIN
- 80-0625749
Board of directors
-
Brenda Jane Larsen-Becker · DirectorSince 2023
-
Catherine Mazzacco · DirectorSince 2023
-
David Badawi · Director · Chief Technology OfficerSince 2023
-
Donald Zurbay · DirectorSince 2023
-
Erica J. Rogers · DirectorSince 2023
-
Gerhard F. Burbach · DirectorSince 2025
-
Paul Badawi · Director · President and CEOSince 2023
-
Staffan Encrantz · DirectorSince 2023
-
Tamara Fountain · DirectorSince 2023
-
Valeska Schroeder · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.9%
-
89.7%
Board connections
5 of this board's directors also sit on 6 other boards. 5 are in the same sector.
- via Gerhard F. Burbach
-
CeriBell Inc. Same sectorvia Erica J. Rogers
-
DENTSPLY SIRONA Inc. Same sectorvia Donald Zurbay
-
Krystal Biotech Inc. Same sectorvia Catherine Mazzacco
-
LivaNova PLC Same sectorvia Donald Zurbay
-
RxSight Inc. Same sectorvia Tamara Fountain
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $184,799
- 2 purchases by 1 insider
- Sold, last 12 months
- $2,865,476
- 38 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 2026 | Bauerlein Alison Officer (Chief Operating Officer) | Open-market sale | −25,260 | $8.85 | $223,627 |
| Oct 2, 2026 | Rodberg James Officer (Chief Financial Officer) | Open-market sale | −7,208 | $8.85 | $63,812 |
| Oct 2, 2026 | Taylor Brenton Officer (EVP, Operations & R&D) | Open-market sale | −2,988 | $8.85 | $26,453 |
| Oct 1, 2026 | David Badawi Director, Officer (Chief Technology Officer) | Open-market sale | −7,797 | $9.05 | $70,555 |
| Oct 1, 2026 | Paul Badawi Director, Officer (President and CEO), 10% owner | Open-market sale | −29,653 | $9.05 | $268,330 |
| Aug 10, 2026 | Rashid Kashif Officer (Chief Legal Officer) | Grant or award | +181,818 | — | — |
| Jul 6, 2026 | David Badawi Director, Officer (Chief Technology Officer) | Open-market sale | −7,418 | $5.51 | $40,873 |
| Jul 6, 2026 | HAYDEN JEREMY B. Officer (Chief Legal Officer) | Open-market sale | −12,733 | $5.51 | $70,159 |
| Jul 2, 2026 | Bauerlein Alison Officer (Chief Operating Officer) | Open-market sale | −24,184 | $5.36 | $129,626 |
| Jul 2, 2026 | Rodberg James Officer (Chief Financial Officer) | Open-market sale | −6,902 | $5.36 | $36,995 |
| Jul 1, 2026 | Paul Badawi Director, Officer (President and CEO), 10% owner | Open-market sale | −28,684 | $5.42 | $155,467 |
| Jul 1, 2026 | Taylor Brenton Officer (EVP, Operations & R&D) | Open-market sale | −2,829 | $5.42 | $15,333 |
| Jun 10, 2026 | Staffan Encrantz Director, 10% owner | Open-market purchase | +14,100 | $4.88 | $68,808 |
| Jun 4, 2026 | Tamara Fountain Director | Grant or award | +28,261 | — | — |
| Jun 4, 2026 | Staffan Encrantz Director, 10% owner | Grant or award | +28,261 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Sight Sciences Inc.
Who is the CEO of Sight Sciences Inc.?
Paul Badawi is Sight Sciences Inc.'s President and CEO.
How many directors are on Sight Sciences Inc.'s board?
Sight Sciences Inc.'s board has 10 directors: Brenda Jane Larsen-Becker, Catherine Mazzacco, David Badawi, Donald Zurbay, Erica J. Rogers, Gerhard F. Burbach, Paul Badawi, Staffan Encrantz, Tamara Fountain and Valeska Schroeder.
Are Sight Sciences Inc. insiders buying or selling shares?
Over the last 12 months, Sight Sciences Inc. insiders bought $184,799 of shares in 2 purchases and sold $2.9 million of shares in 38 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="sight-sciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.